Junseok Jeon

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Biomimetic Soft Actuator: Design, Modeling, Control, and Applications

Hyouk Ryeol Choi, Kyung Uk Jung, S.M. Ryew et al. · IEEE/ASME Transactions on Mechatronics · 2005 · 112 citations

Engineering, Actuator Functionality, Mechanical Engineering +17

Association between diuretics and successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury

Junseok Jeon, Do Hee Kim, Song In Baeg et al. · Critical Care · 2018 · 52 citations · Full text

Cardiovascular Risk Comparison between Expanded Hemodialysis Using Theranova and Online Hemodiafiltration (CARTOON): A Multicenter Randomized Controlled Trial

Yeon‐Hee Lee, Myoung‐jin Jang, Junseok Jeon et al. · Scientific Reports · 2021 · 26 citations · Full text